some branded formulations are also used for chronic weight management in appropriate patients
In the GLP1-RA group 1757 (10.9%) people experienced an event, compared to 1782 (11.1%) within the DPP4i group (OR 0.98, 95% CI 0.92 to 1.06, p = 0.66)
Primarily, Mounjaro is used for blood sugar control in type 2 diabetes patients, while Zepbound is FDA-approved for promoting weight loss and weight-related complications like moderate to severe obstructive sleep apnea
Indeed, initial preclinical studies employing radiolabeled tracers have indicated that acylated GLP-1 analogs, such as liraglutide and semaglutide, exhibit markedly limited brain penetration compared to their smaller non-acylated counterparts (Salameh et al., 2020)
4 Its also heavily underdiagnosed, particularly in people who dont sleep next to a partner who notices it
However, studies that include a larger number of patients treated with both SGLT2i and finerenone are needed